Company: INCR
Filing Date: 2025-05-01
Form Type: 20-F
Source: 0001641172-25-007971
Chunk: 56

Company: Intercure Ltd.
Filing Date: 2025-05-01
Form: 20-F
Item: Item 4
Chunk 56
---

--

●                                                                    Ahuza                                                                 
            Pharmacy D.Y.’s operations are focused on managing and operating a pharmacy in the city of Ra’anana. The Ahuza pharmacy        
                                              is yet to be approved for selling medical cannabis.                                          
-------------------------------------------------------------------------------------------------------------------------------------------
●   Orni                                                                                                                                   
    Pharmacy Ltd.’s operations are focused on managing and operating a pharmacy in the city of Tel-Aviv.                                   
●   Arihut                                                                                                                                 
    Yamim Pharmacy Ltd.’s operations are focused on managing and operating a pharmacy in the city of Ashdod. As of the date of             
    this Annual Report, we have asserted claims against the prior owners in relation to this company. A legal dispute is currently ongoing.
●   Amidar                                                                                                                                 
    Pharmacy Ltd.’s operations are focused on managing and operating a pharmacy in the city of Naharia.                                    
●   Medicine                                                                                                                               
    Center G.G Pharmacy Ltd.’s operations are focused on managing and operating a pharmacy in the city of Bnei Brak.                       
Our Strengths
 
We believe our key competitive strengths include the following:
 
We have been a pioneer of cannabis for medical use for over 17 years. We have been producing cannabis for medical use since 2008 and are one of the first licensed producers and distributors of cannabis and cannabis-based products in Israel. We were the first to import cannabis for medical use into Israel for distribution in the Israeli market and we were the first to export cannabis for medical use to a country in the European Union.
 
Our products and processes meet the highest standards required by regulators for the whole value-chain of pharmaceutical-grade cannabis. We were one of the first cannabis companies in Israel to supply products that meet the GMP standards established by the IMCA. Our facilities and the production processes implemented in them are certified under the IMC-GAP standards and comply with the Good Agriculture Collection Practices (“GACP”) following an audit made by an EU-GMP-certified entity. Finally, our distributors, including pharmacies, store and distribute our products using facilities and processes that meet the IMC-GDP standards. Our products comply with the highest standards, and we believe our products will be competitive in any medical-use cannabis market.
 
Strategic Partnerships. We have entered into long-term exclusive strategic partnerships with leading companies of the industry. We have exclusive long-term partnerships with Tilray, Organigram, Charlotte’s Web Inc. (TSX: CWEB) (OTCQX: CWBHF) (“Charlotte’s Web”), Cookies